HealthInvestor Executive Moves
 
 
Remember me:
HealthInvestor Executive moves The latest appointments in the independent healthcare industry


Octopus Real Estate: Chris Wishart

Octopus Real Estate, part of Octopus Group and a UK specialist real estate lender and investor, has appointed Chris Wishart as director of origination. 

Chris will take a leading role in Octopus Real Estate’s care home investment team, finding and delivering elderly and specialist care real estate acquisitions for its institutionally backed funds. 

Octopus Real Estate’s market-leading care homes team currently manages a portfolio of 60 modern, purpose-built homes, including 9 properties under construction, with a market value of over £750 million.

Chris joins from Savills, where he has been a Director in the healthcare practice since 2017. Prior to this Chris was a Partner at Knight Frank where he was instrumental in building a market leading healthcare consultancy team.  

Benjamin Davis, CEO at Octopus Real Estate, said: “Chris’s significant experience in the healthcare market speaks for itself, and we are delighted that he is joining us. Chris will add further strength to our market-leading care homes team as we continue to grow the portfolio and strive to enhance our offering to both investors and operators in a market that remains undersupplied.”

Posted on: 29/05/2020

Latest news stories

03/07/2020
The number of people considering paying for private treatment or health insurance has significantly increased since the Covid-19 outbreak, despite the impact of the pandemic on personal finances, according to new research.
01/07/2020
Researchers from King’s Business School say that the care sector needs a new model of employment relations to tackle the challenges exposed by the Covid-19 crisis.
01/07/2020
The number of deals announced in the global healthcare sector fell by 12% during the week ended June 28, according to GlobalData’s deals database
30/06/2020
Health leaders have voiced concerns that the government’s messaging on pandemic mitigation is “clouded in confusion”.
30/06/2020
Beckley Psytech has raised £3m of Series A funding to develop a pipeline of psychedelic drugs into licensed pharmaceutical medicines for treating psychiatric and neurological diseases.





HealthInvestor Feature

Consultant profile

Introducing: Kieran Mouser

As Senior Associate of the Finance and IT Practice at Compass Executives, Kieran is responsible for delivery into the investor and privately backed health and social care sectors, specialising in board level CFO, FD, IT and Programme Director mandates.

With a background in boutique finance executive recruitment, Kieran has a successful track record of delivering cross-functional searches for a broad range of clients, with notable placements across a range of assignments. Compass Executives
To find out more about Kieran, or to contact him about new opportunities, please contact kieran@compassexecs.co.uk or call 7860 355 504.


2019 InvestorPublishing. HealthInvestor.co.uk